Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is a potentially useful tool for the detection of antimicrobial resistance, especially that conferred by ␤-lactamases. Here we describe a modification of a previously reported MALDI-TOF MS meropenem hydrolysis assay. The modified method was validated on 108 carbapenemase-producing members of the Enterobacteriaceae, two NDM-1-producing Acinetobacter baumannii isolates, and 35 carbapenem-resistant enterobacteria producing no carbapenemase. The detection of carbapenemases by MALDI-TOF MS seems to be a powerful, quick, and cost-effective method for microbiological laboratories. D etection of carbapenemases has been one of the challenges in clinical microbiology diagnostics (9). Recently, new matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) assays for ␤-lactamase activity have been developed independently by at least three groups (2, 7, 12). These techniques are based on the detection of ␤-lactams and their degradation products. A similar assay was validated to detect carbapenemases in Acinetobacter baumannii (8).
D etection of carbapenemases has been one of the challenges in clinical microbiology diagnostics (9) . Recently, new matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) assays for ␤-lactamase activity have been developed independently by at least three groups (2, 7, 12) . These techniques are based on the detection of ␤-lactams and their degradation products. A similar assay was validated to detect carbapenemases in Acinetobacter baumannii (8) .
However, for some ␤-lactams, like meropenem, visualization of degradation products by MALDI-TOF MS seemed to be problematic (7, 12) . This might be due to binding of the molecules to cell lysate components. Here we describe a modification of one of these protocols (7) that allows the detection of degradation products and shortening of the turnaround time to ca. 2.5 h. The mod-ified assay was validated with NDM-1-, VIM-1-, KPC-2-, KPC-3-, and OXA-48/-162-producing members of the Enterobacteriaceae and NDM-1-producing A. baumannii isolates.
(The data included in this article were presented in part as a poster at the 22nd European Congress of Clinical Microbiology (Table 1 ). Almost all of the isolates had been well characterized previously on the molecular level (1, 5, 6, 10, 11) . For the newly included isolates, carbapenemase production was verified by the imipenem hydrolysis spectrophotometric assay (13), followed by PCR and sequencing of the carbapenemase genes (1, 5, 6, 11) . Species identification was performed using a MALDI Biotyper system, version 3.0 (Bruker Daltonics, Bremen, Germany). Thirty-five non-carbapenemase-producing isolates resistant to carbapenems (4), identified in the Czech Republic, were also included ( Table 1 ). Most of these isolates had been characterized in detail previously (3); in several new ones, carbapen-emase production was excluded by the spectrophotometric assay (13) .
The meropenem hydrolysis assay (7) was performed as previously described, with modifications. An overnight bacterial culture on Mueller-Hinton agar (Bio-Rad Laboratories, Prague, Czech Republic) was suspended in 20 mM Tris-HCl-20 mM NaCl, pH 7.0 (Sigma-Aldrich, Prague, Czech Republic), to a density equivalent to a 3.0 McFarland standard. In our experience, other common cultivation media (e.g., Columbia agar) can be used as well. The 1-ml aliquot of the suspension was centrifuged; the pellet was resuspended in 50 l of a reaction buffer (20 mM Tris-HCl, 0.01% sodium dodecyl sulfate [SDS], pH 7.0; Sigma-Aldrich), supplemented with 0.1 mM meropenem (Astra Zeneca, Macclesfield, United Kingdom). After incubation at 35°C for 2 h, the reaction mixture was centrifuged; 1 l of the supernatant was immediately mixed with 1 l of dihydroxybenzoic acid solution (DHB) (Sigma-Aldrich) and allowed to dry on a target. Spectra were measured after drying between m/z 160 and 600, using a Microflex LT mass spectrometer (Bruker Daltonics). The measurements must be performed immediately after drying of the samples because a delay of more than 1 h may cause degradation of meropenem and its variants. The laser range was set up individually to obtain spectra with intensities between 0.2 ϫ 10 4 and 2.0 ϫ 10 4 (ca. 60 to 90%). Calibration was performed using meropenem and its two sodium salt variants (m/z 384.5, 406.5, and 428.5).
Spectra were analyzed by using the software program flex-Analysis, version 3.3 (Bruker Daltonics), in the range between m/z 350 and 480 ( Fig. 1) . For the carbapenemase-producing isolates, two products of meropenem degradation were identified, with m/z values of 358.5 (the decarboxylated product) and 380.5 (sodium salt of the decarboxylated product). For some carbapenemase-positive strains, other degradation products were observed (e.g., three sodium salt variants with m/z 424.5, 446.5, and 468.5) ( Table 1 ). Meropenem (m/z 384.5) and its monosodium salt (m/z 406.5) were not detected. For the non-carbapenemase-producing isolates, no peaks with m/z 358.5 and 380.5 were recorded, but meropenem and its monosodium salt were present.
According to the results, the detection interpretation criteria were established (see Table 2 ). Using these criteria, it was possible to identify carbapenemase activity in all carbapenemase-positive isolates used in the study. There were neither false-positive nor false-negative results.
The main modification of the method published previously (7) was the supplementation of the reaction buffer with SDS, resulting in a decrease of the amount of bacterial cells and reduction of the incubation time to 2 h. The MALDI-TOF MS meropenem hydrolysis assay was validated mainly with carbapenemase-producing members of the Enterobacteriaceae, and in our opinion it can be used in microbiological laboratories for these organisms routinely. 
